Log In
Print
BCIQ
Print
Print this Print this
 

MSDC-0160 (formerly mitoglitazone)

  Manage Alerts
Collapse Summary General Information
Company Metabolic Solutions Development Co.
Description mTOT modulating insulin sensitizer
Molecular Target Mitochondrial pyruvate carrier 1 (MPC1) (BRP44L) ; Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today